复发/难治性多发性骨髓瘤临床实践中基于抗 CD38 治疗的共识指南与推荐：来自泛太平洋多发性骨髓瘤工作组 Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-P PubMed 2025/08/08 发表Clin Hematol Int 靶点：CD38技术：CAR-T技术：双特异性抗体多发性骨髓瘤地区：中国地区：韩国
肿瘤细胞治疗研究
